SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A recent market pullback and the anniversary of the 1987 Black Monday crash have fueled fears of a deeper selloff, though traders are split on whether the concern is overblown. Some expect further downside amid weakness in tech and AI stocks, while others point to firmer futures and crowded bearish positioning as reasons for a relief bounce.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp technology- and AI-linked selloff has put QQQ under pressure, with traders debating whether concerns about AI spending and financing signal further weakness or whether oversold conditions will prompt a rebound. Some expect a relief rally, while others warn of broader market downside; upcoming big-tech earnings are seen as a test of sentiment.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Crudes rally is being tied to Middle East shipping and energy-infrastructure risks, especially reported attacks near the Strait of Hormuz, alongside concerns about Russian refinery disruptions and tight supplies. Bulls see a persistent supply squeeze, while bears argue that diplomacy or additional Russian fuel supplies could unwind the war premium.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Discussion centers on Iovances ESMO data, especially lifileucel combinations in melanoma and results in sarcoma. Traders are divided over whether the abstracts offer new, mature data or largely repeat an earlier dataset; some view the reported clinical signal positively, while others are waiting for clearer numbers and durability details. The share decline is also widely attributed to broader biotech and market weakness rather than a confirmed IOVA-specific setback.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is drawing attention for its choppy, rangebound trading, with traders debating whether support will hold and a breakout can follow or whether the token will keep fading. Bullish holders are accumulating and calling for a reversal, while skeptics point to persistent weakness and continued selling pressure.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

Traders are focused on KOLD as a way to position for lower natural-gas prices, citing strong production, ample storage and mild-weather or shoulder-season demand as bearish pressures. The discussion is divided, with some favoring KOLD while others point to heat, storage surprises and pipeline or LNG disruptions as potential sources of sharp reversals.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is being swept up in a sharp semiconductor and AI-stock selloff as traders question the durability and profitability of AI infrastructure spending amid inflation and interest-rate concerns. The community is split between viewing the decline as an oversold buying opportunity, citing foundry and customer prospects, and expecting further losses; claims of manipulation or forced liquidations remain speculation.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins choppy trading near a closely watched support zone, alongside reports of leveraged long liquidations, is driving discussion. Bulls see a defended base and possible short squeeze, while bears warn of further downside; ETF outflows and macro concerns add to the caution.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accentures fiscal Q4 earnings beat and record bookings have driven a sharp rally, easing concerns that AI will undermine demand for its consulting and implementation work. Traders remain divided over whether bookings signal durable demand or whether modest growth expectations and AI-driven pressure on traditional consulting could limit the rebound.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

A sharp UVXY move has focused attention on rising volatility and fears tied to geopolitical tensions, oil prices, higher yields, and potential market weakness. Traders are split between expecting a further volatility spike and shorting the bounce, while many stress that UVXY tracks short-term VIX futuresnot spot VIXand can lose value through contango and decay.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vaso Stock Surges 149% in a Year: What's Behind the Rally?

VASO is gaining from higher equipment deliveries, growing deferred commissions and a sharper healthcare focus, though partner dependence and margin pressures persist.

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing rigorous evidence of the significant benefits of continuous glucose...

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom's strong margins, G7 15-day rollout and promising pipeline support its growth outlook, but factory ramp-up costs, forex and input-price pressures pose risks.

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the company's third quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the...

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the companys one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.This press release features multimedia. View the full...

DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care

Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.

Here's Why DexCom (DXCM) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept...

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the promotion of Jereme Sylvain to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer. In this expanded role, Mr. Sylvain will assume oversight of Dexcoms global...

DXCM's strong growth, G7 15 Day adoption and CONNECT trial could expand its CGM market opportunity despite reimbursement and competition risks.

Dexcom, Inc.. The group's principle activity is designing & developing of medical devices for continuous monitoring of glucose in people with diabetes. It has developed proprietary technology and expertise that enable it to develop two continuous glucose monitoring systems: a short-term system with a sensor that can be inserted by a patient and used continuously for three days, and a long-term system with a sensor that can be implanted by a physician in a short outpatient procedure requiring only local anesthesia, and can be used for up to one year. On 13-Feb-2009, it received approval from the FDA for its third generation continuous glucose monitoring system.

Dexcom Inc

Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$DXCM (Dexcom) shares fell 1.1% to close at $87.93 as rising Treasury yields and stronger-than-expected economic data pressured healthcare and tech names heading into Thursday's open.

Quassar Capital

$DXCM: eight Dexcom breach suits sit with six judges in San Diego, not yet consolidated. On Oct 14 one case moved to the first judge under the low-number rule. Breach still unconfirmed, nothing to claim. Open Class Actions.

Clam Clamwell

$DXCM: the Dexcom breach suits jumped from three to eight. Five more were filed Oct 13-14 in San Diego, all off the ShinyHunters listing Dexcom still has not confirmed. No class certified, nothing to claim. Open Class Actions.

$DXCM why do people trade at this level while it is mooning based on the data. beats me😂

YoBiDing

$DXCM: Published CONNECT trial data showed Dexcom's G7 cut A1C by 1.6% and added five daily hours in the target range.

Briefing.com

$DXCM case watch: three overlapping breach suits in San Diego may consolidate before one judge. All rest on a ShinyHunters listing with no sample files posted, and Dexcom has not confirmed a breach. Nothing to claim. Open Class Actions.

$DXCM 
There’s no reason this should be under $90, I mean really, even seeking Alpha has a strong buy so wtf 🤦🏼‍♀️￼

Feed

News

Sentiment

Earnings

Fundamentals

Info

DXCM Dexcom Inc

Fundamentals

Latest DXCM News